Current Position: Product Center
Anti-CD40 hIgG1 Reference Antibody (Sotibio)
Cat. No.
GM-87984MAB
Size
Quote
Related products
Product info
Cat. No. & Size
Description️
Data
Related products
Product info

Cat.No:GM-87984MAB

Product :Anti-CD40 hIgG1 Reference Antibody (Sotibio)


Cat. No. & Size

GM-87984MAB-1mg / 1 mg

GM-87984MAB-5mg / 5 mg

GM-87984MAB-25mg / 5 mg * 5 vials

GM-87984MAB-50mg / 50 mg

GM-87984MAB-100mg / 50 mg * 2 vials


Description️

Expression System            CHO

Aggregation                 < 5% as determined by SEC-HPLC

Purity                            >95% as determined by SDS-PAGE

Endotoxin                     <1 EU/mg, determined by LAL gel clotting assay

Sterility                          0.2 μm Filtered

Target                                CD40

Clone                                 Sotigalimab

Alternative Names           Bp50, CDW40, TNFRSF5, p50

Source/Isotype               Monoclonal Human IgG1(KDEL,S267E), Kappa

Application                     /

Description                       CD40 (also known as Bp50, CDW40, TNFRSF5, and p50) is a membrane protein receptor encoded by the CD40 gene, located on human chromosome 20q13. Sotigalimab (also known as APX005M) is a non-agonistic monoclonal antibody targeting CD40, belonging to the emerging field of cancer immunotherapy. As an anti-CD40 antibody, Sotigalimab activates the CD40 signaling pathway to enhance antigen presentation and stimulate immune responses, thereby boosting the body's antitumor immunity.

Formulation                   phosphate-buffered solution, pH 7.2-7.4.



Data

image.png

image.png



Anti-CD40 hIgG1 Reference Antibody (Sotibio)
Cat. No.
GM-87984MAB
Size
Quote
Related products
Product info
Cat. No. & Size
Description️
Data
Related products
Product info

Cat.No:GM-87984MAB

Product :Anti-CD40 hIgG1 Reference Antibody (Sotibio)


Cat. No. & Size

GM-87984MAB-1mg / 1 mg

GM-87984MAB-5mg / 5 mg

GM-87984MAB-25mg / 5 mg * 5 vials

GM-87984MAB-50mg / 50 mg

GM-87984MAB-100mg / 50 mg * 2 vials


Description️

Expression System            CHO

Aggregation                 < 5% as determined by SEC-HPLC

Purity                            >95% as determined by SDS-PAGE

Endotoxin                     <1 EU/mg, determined by LAL gel clotting assay

Sterility                          0.2 μm Filtered

Target                                CD40

Clone                                 Sotigalimab

Alternative Names           Bp50, CDW40, TNFRSF5, p50

Source/Isotype               Monoclonal Human IgG1(KDEL,S267E), Kappa

Application                     /

Description                       CD40 (also known as Bp50, CDW40, TNFRSF5, and p50) is a membrane protein receptor encoded by the CD40 gene, located on human chromosome 20q13. Sotigalimab (also known as APX005M) is a non-agonistic monoclonal antibody targeting CD40, belonging to the emerging field of cancer immunotherapy. As an anti-CD40 antibody, Sotigalimab activates the CD40 signaling pathway to enhance antigen presentation and stimulate immune responses, thereby boosting the body's antitumor immunity.

Formulation                   phosphate-buffered solution, pH 7.2-7.4.



Data

image.png

image.png



Message consultation
reset
submit
Message
Message consultation
reset
submit